The biotechnology market in the US has witnessed a rapid expansion in
recent years driven by increased biotechnology applications in various sectors
such as agriculture, food, health, medical and environmental sciences. The
application in the human health dominates the US biotechnology market followed
by agricultural and industrial applications. The biotechnology industry in the
US is comprised of large multinational corporations, small entrepreneurial
firms, various public and private research entities, dedicated biotechnology
investment companies, bioinformatics companies and academia. The US
biotechnology industry revenues have increased from USD 73 billion in 2006 to
USD ~ billion in 2011 by growing at a CAGR of ~% during 2006-2011. The falling
supply and production of oil, gas and coal and wide attention to the
environmental impacts has also increased the demand for biotechnology engineered
energy sources such as biofuels.
The US biotechnology market can be classified into three segments- Bio-Pharma,
Industrial biotechnology and Agricultural biotechnology. The bio-pharma
represents the largest segment in the US biotechnology market. This is followed
by industrial biotechnology which is the second largest contributor in the US
biotechnology market. Biologic drugs are gradually increasing their share over
the period. Biological drugs are generally more expensive than the conventional
drugs thus acting as a key revenue earners for producers. The total US biologic
drugs market grew from USD ~ billion in 2006 to USD ~ billion in 2011 at a 5
year CAGR of 7.7%. Biologic drugs has high potential for future growth because
of better long term outcomes with fewer costly side effects. Bristol-Myers
Squibb is the largest company in the US in terms of biopharmaceutical drugs
sales. The company held a market share of ~% and recorded sales of USD ~
billion. The company focuses on developing drugs in the oncology therapeutic
class.
The agricultural biotechnology in the US is widely popular among farmers
owing to the benefits of tools like genetic engineering that has made crop
production cheaper and more manageable. The use of biotech crops that are
unaffected by plant diseases and insect pests also have reduced the use of
synthetic pesticides. The US agricultural biotechnology market has grown at a
CAGR of ~% during 2006-2011 to USD ~ million in 2011.
The biotech crops accounts for majority of the US agricultural
biotechnology market while the bio-pesticides contribute very less as compared
to biotech crops. The contribution of biotech crops in the US agricultural
biotechnology market have increased from ~% to ~% over the five year duration of
2006-2011 while on the other hand the contribution of bio-pesticides have
declined from ~% to ~% during the same period.
In 2011, the US accounted for almost 3/4th of the total biotech crop
production across the world with total hectarage of ~ million hectares dedicated
to the production of biotech crops. The bio-pesticides market in the US has
recorded a CAGR of ~% during 2006-2011. After 2009, the market gained momentum
again and was recorded at USD ~ million in 2011. This reflects an increase in
the adoption of bio-pesticides by the US farmers as a replacement to the toxic
chemical pesticides. The various segments for the consumption of bio-pesticides
in the US market are organic agricultural industry, vegetable farming, orchard
crops and berries, federal and municipal programs for the management and
treatment of forests, water resources and green belts in urban areas.
The development and adoption of industrial biotechnology has witnessed an
unprecedented growth in the US in last five years. The substitution of
conventional liquid fuels with liquid biofuels is widely considered as an
important step towards energy security by reducing crude petroleum imports. The
biofuel industry in the US grew at a CAGR of ~% from the period 2006-2011. The
market in the US has increased by ~% in 2011 to USD ~ million due to rise in the
government mandate blending rate targets. In the US the Environmental Protection
Agency (EPA) has mandated a minimum level of biofuel consumption between 2006
and 2022. The market is expected to experience a CAGR of 12.1% from 2012-2016
following which the industry is expected to record revenue of USD ~ million in
2016. The US market for industrial enzymes can be categorized into – Detergent
Enzymes, Technical Enzymes, Food & beverage enzymes and Animal Feed enzymes. The
US market for bio-enzymes was registered revenues of USD ~ million in 2011 while
in 2006 the size of the market was USD ~ million. This accounts for a CAGR of ~%
during 2006-2011.
The various trends such as growing old population, increasing emphasis on
the sustainable renewable energy alternatives to reduce the dependency on the
import of the oil, decreasing arable land and the increasing demand for food and
the ability of biotech products and services to meet all these demands are
expected to drive the US biotechnology market positively in next five years. Due
to these factors the US biotechnology market is expected to grow at a CAGR of
10.2% during 2012-2016 to reach USD ~ million in 2016 from USD ~ million in
2012.
Key Topics Covered in the Report:
• The market size of the US Biotechnology Market by revenue for the period
2006-2011.
• Market segmentation of the US biotechnology market on the basis of
bio-pharmaceuticals, agricultural biotechnology and industrial, 2006-2011.
• Market size, introduction and future outlook/projections of the US
bio-pharmaceutical market.
• Company Profiles of major companies in the US bio-phrmaceuticals market.
• Market size, introduction and future outlook/projections of the US
agriculture biotechnology market.
• Market segmentation of the US agricultural biotechnology market on the
basis of biotech crops and bio-pesticides.
• Market size, introduction and future outlook/projections of the biotech
crops and bio-pesticides market of the US.
• Trends and Development of the US agricultural biotechnology market.
• Company Profiles of major companies in the US agricultural biotechnology
market.
• Market segmentation of the US industrial biotechnology market on the
basis of biofuels and bio-enzymes.
• Market size, introduction and future outlook/projections of the biofuels
and bio-enzymes market of the US.
• Trends and Development of the US industrial biotechnology market.
• Company Profiles of major companies in the US bio-enzymes market.
• Future outlook and projections of the US biotechnology market,
2012-2016.
